beta, beta-dimethylacrylshikonin has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jian, C; Jiao, Y; Li-Ming, Z; Shao-Ju, J; Xiao-Wei, Z; Yao, X; Ying-Ying, F; Yuan-Yuan, Z; Zhen-Jun, S | 1 |
| Chen, JH; Ma, XQ; Shen, XJ; Wang, HB | 1 |
2 other study(ies) available for beta, beta-dimethylacrylshikonin and Stomach Neoplasms
| Article | Year |
|---|---|
β,β-Dimethylacrylshikonin exerts antitumor activity via Notch-1 signaling pathway in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drugs, Chinese Herbal; Female; G1 Phase; Humans; Mice; Mice, Inbred BALB C; Naphthoquinones; Receptor, Notch1; Resting Phase, Cell Cycle; Signal Transduction; Stomach Neoplasms; Transplantation, Heterologous | 2012 |
β,β-Dimethylacrylshikonin induces mitochondria dependent apoptosis through ERK pathway in human gastric cancer SGC-7901 cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Mitochondria; Naphthoquinones; Signal Transduction; Stomach Neoplasms | 2012 |